Along with the increase in the pleomorphism of neoplastic cells and the degree of histopathological malignancy of the tumor, an increase in TFPI expression and loss of TFPI-2 expression has been found, which indicates a different role for both of the TF inhibitors in the biology of gliomas of varying degrees of malignancy. The gene discussed is TFPI2; the disease is central nervous system cancer.